2020
DOI: 10.1016/j.ica.2019.119263
|View full text |Cite
|
Sign up to set email alerts
|

Structural studies on thiosalicylate complexes of Zn(II) & Hg(II). First insight into Zn(II)-thiosalicylate complex as potential antibacterial, antibiofilm and anti-tumour agent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 54 publications
0
4
0
Order By: Relevance
“…The peaks of Zn‐MBA at about 251 and 301 nm corresponded to the π→π* transition of benzene ring (Figure S25, Supporting Information). [ 24 ] Peak shifts and absorption maxima that are shifted to higher energy indicate that the spectra of these materials would show additional overlapping absorptions bands if other metal complexes resided in the pores; the lack of such electronic absorption features further supported the assertion that substitution occurs at the metal nodes. [ 23 ] XRD patterns of the Zn‐MBA materials after metathesis, shown in Figure 5b, confirm that the material retained the Zn‐MBA crystal structure, and discrepancies in peak intensities are due to preferential orientation.…”
Section: Resultsmentioning
confidence: 96%
“…The peaks of Zn‐MBA at about 251 and 301 nm corresponded to the π→π* transition of benzene ring (Figure S25, Supporting Information). [ 24 ] Peak shifts and absorption maxima that are shifted to higher energy indicate that the spectra of these materials would show additional overlapping absorptions bands if other metal complexes resided in the pores; the lack of such electronic absorption features further supported the assertion that substitution occurs at the metal nodes. [ 23 ] XRD patterns of the Zn‐MBA materials after metathesis, shown in Figure 5b, confirm that the material retained the Zn‐MBA crystal structure, and discrepancies in peak intensities are due to preferential orientation.…”
Section: Resultsmentioning
confidence: 96%
“…Moreover, the complex with mixed ligands [Zn(tsa)(tmeda)] 2 ( 65 ) (Htsa: thiosalicylic acid; tmeda: N , N , N ′, N ′-tetramethylethylenediamine) is very active on the old biofilms of S. aureus , as indicated in the studies performed by confocal laser scanning microscopy which revealed its bactericidal activities, possibly by membrane alterations, as demonstrated by the propidium iodide (PI) uptake [ 142 ].…”
Section: Complexes With Antibiofilm Activitymentioning
confidence: 99%
“…Thiosalicylate complexes of Zn(II) and Hg(II), [Zn(SC 6 H 4 CO 2 )(TMEDA)] 2 , were shown to have potent antimicrobial and antibiofilm activities against E. coli , whereby complete degradation of E. coli biofilms was achieved at relatively small concentration of 0.227 μg/mL. Hence, the study suggested that the complexes hold great promise for the development of a new class of antibacterial and antibiofilm agents to combat the resistant pathogens [ 72 ]. Thiosalicylate complexes of Zn(II) and Hg(II), [Zn(SC 6 H 4 CO 2 )(TMEDA)] 2 , were also shown to exert anti-tumor actions against the colon cancer cell line HCT116 [ 72 ].…”
Section: Strategies To Target Gut Microbial Biofilmsmentioning
confidence: 99%
“…Hence, the study suggested that the complexes hold great promise for the development of a new class of antibacterial and antibiofilm agents to combat the resistant pathogens [ 72 ]. Thiosalicylate complexes of Zn(II) and Hg(II), [Zn(SC 6 H 4 CO 2 )(TMEDA)] 2 , were also shown to exert anti-tumor actions against the colon cancer cell line HCT116 [ 72 ]. Thus, it is worthwhile exploring the clinical use of thiosalicylate complexes as promising agents for preventing CRC.…”
Section: Strategies To Target Gut Microbial Biofilmsmentioning
confidence: 99%